The jointly-funded postdoctoral fellowship scheme is helping to support the next generation of scientists 和 foster collaborations between academia 和 industry.
This postdoctoral fellowship scheme is co-funded with the Medical Research Council (MRC), 是英国研究与创新的一部分, 和 aims to drive research progress on types of advanced therapies known as cell 和 oligonucleotide therapies. 来自60多个杰出领域的应用程序, a rigorous selection process has resulted in fellowships for seven successful c和idates.
Ryan Hicks, Senior Director of Cell Therapy, 澳门葡京赌博游戏 R&D、澳门葡京网赌游戏, talks about the exciting potential of the seven projects we are co-funding with the MRC
Advanced therapies could revolutionise treatments for disease over the coming decades. 获得资助的项目包括心血管方面的项目, 肾脏和免疫系统疾病以及糖尿病. 研究还侧重于了解患者安全, delivery in the human body 和 interactions with the immune system for these next generation therapeutics.
Advanced therapies have the potential to provide new ways to treat previously untreatable diseases, making it possible to develop medicines to address significant unmet needs.
细胞疗法 修理工作, 替换, modulating or eliminating diseased or damaged cells 和 tissue using stem cells, 来自捐赠者的健康细胞或基因工程细胞. 细胞疗法 can also be used to deliver therapeutic drugs to a specific part of the body.
寡核苷酸治疗 are short pieces of DNA or RNA that target disease by silencing or switching on genes. 
The scheme has awarded funding to seven UK-based postdoctoral researchers:
- Dr Holly Foster at the University of 剑桥 working with Professor Cédric Ghevaert
- Dr Francesco Galli, working with Professor Clare Baldock at the University of Manchester
- Dr Christos Georgiadis in the group of Professor Waseem Qasim, at University College London
- Dr Francois Halloy at the University of Oxford with Professor Matthew Wood
- Dr Oladapo Olaniru at Kings College London with Professor Shanta Persaud
- Dr Lay Ping Ong with Dr Catherine Wilson at the University of 剑桥
- Dr Lyra R和zavola with Professors Marina Botto 和 Anastasios Karadimitris at Imperial College London
每个研究员将获得资金，以使学术主导, 独立研究, while supporting the recipients to develop links with industry through secondments, 培训和指导机会. Their projects will involve working with stem cells 和 primary immune cells 和 will make use of technologies including 基因编辑 和 有针对性的交付.
MRC recognises the importance of supporting postdoctoral researchers at key transition points in their careers. We are especially pleased to be co-funding this exciting cohort of future research leaders. Our industry-academic partnership with 澳门葡京网赌游戏 will not only allow fellows to improve their knowledge about the translational pipeline 和 the contribution of commercial organisations to healthcare innovation, but will also provide an opportunity to develop the skills necessary to turn their 独立研究 ideas into new knowledge 和 improve health outcomes. We look forward to following the outcomes of their projects into advanced therapies.
我期待着与这些新同事合作, 推动重要的研究向前发展. Each research proposal has the potential to make a real-world impact 和 to transform lives by delivering progress in advanced therapeutics. This is a fantastic example of how collaboration between academia 和 industry can lead to exciting 和 productive discoveries that combine the strengths of all involved.
